Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders

American Journal on Addictions

Volumn 15, Issue 2, 2006, Pages 166-173

  Stuyt, Elizabeth B ^a,b   Sajbel, Terrie A ^a   Allen, Michael H ^b  

^a Colorado Mental Health Institute at Pueblo   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUPHENAZINE; HALOPERIDOL DECANOATE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; FEMALE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION; PSYCHOSIS; RETROSPECTIVE STUDY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUBSTANCE ABUSE;

ADULT; ALCOHOLISM; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; COCAINE-RELATED DISORDERS; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; FLUPHENAZINE; HALOPERIDOL; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MARIJUANA ABUSE; MIDDLE AGED; MOTIVATION; OUTCOME ASSESSMENT (HEALTH CARE); PIPERAZINES; PSYCHOTIC DISORDERS; RISPERIDONE; SCHIZOPHRENIA; SMOKING; SUBSTANCE-RELATED DISORDERS; THIAZOLES;

EID: 33645765317     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490500528613     Document Type: Article

References (33)

1. Simpson DD, Sells SB. Effectiveness of treatment for drug abuse: an overview of the DARP research program. Advances in Alcohol and Substance Abuse. 1982;2:7-29.
2. Hubbard RL, Marsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug Abuse Treatment: A National Study of Effectiveness. Chapel Hill, NC: The University of North Carolina Press; 1989.
3. Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM. Overview of one-year follow-up in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav. 1997;11:261-278.
4. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA. 1990;264: 2511-2518.
5. Drake RE, Essock SM, Shaner A, et al. Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv. 2001;52:469-476.
6. Owen RR, Fischer EP, Booth BM, et al. Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr Serv. 1996;47:853-858.
7. Hughes JR, Hatsukami DK, Mitchell JE, et al. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry. 1986;143: 993-997.
8. Stuyt EB. Recovery rates after treatment for alcohol/drug dependence, tobacco users vs. non-tobacco users. Am J Addict. 1997;6:159-167.
9. Reid MS, Michalian JD, Delucchi KL, Hall SM, Berger SP. An acute dose of nicotine enhances cue-induced cocaine craving. Drug Alcohol Depend. 1998;49:95-104.
10. Frosch DL, Nahom D, Shoptaw S, Jarvik ME. Associations between tobacco smoking and illicit drug use among methadone-maintained opiate-dependent individuals. Exp Clin Psychopharmacol. 2000;8:97-103.
11. Buckley PF. Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia. J Subst Abuse Treat. 1998;15:113-116.
12. Drake RE, Xie H, McHugo GJ, et al. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull. 2000;26:441-449.
13. Zimmet SV, Strous RD, Burgess ES, et al. Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. J Clin Psychopharmacol. 2000;20:94-98.
14. Albanese MJ. Safety and efficacy of risperidone in substance abusers with psychoses. Am J Addict. 2001;10:190-191.
15. Gupta N, Basu D. Does risperidone reduce concomitant substance abuse in cases of schizophrenia? Can J Psychiatry. 2001;46:862-863.
16. Smelson DA, Roy A, Roy M. Risperidone and neuropsychological test performance in cocaine-withdrawn patients. (Letter.) Can J Psychiatry. 1997;42:431.
17. Littrell KH, Petty RG, Hilligoss NM, et al. Olanzapine treatment for patients with schizophrenia and substance abuse. J Subst Abuse Treat. 2001;21:217-221.
18. Noordsy DL, O'Keefe C. Effectiveness of combining atypical antipsychotics and psychosocial rehabilitation in a community mental health center setting. J Clin Psychiatry. 1999;60(suppl. 19):47-51.
19. Noordsy DL, O'Keefe C, Mueser KT, et al. Six-month outcomes for patients who switched to olanzapine treatment. Psychiatr Serv. 2001;52:501-507.
20. Brown ES, Nejtek VA, Perantie DC, Bobadilla L. Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disord. 2002;4:406-411.
21. Avants SK, Margolin A, Holford TR, et al. A randomized controlled trial of auricular acupuncture for cocaine dependence. Arch Intern Med. 2000;160:2305-2312.
22. Prochaska JO, Diclementi CC, Norcross JC. Changing for Good. New York, NY: Basic Books; 1986.
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
24. SAS Institute Inc. StatView® 5 Reference. Cary, NC: SAS Institute Inc.; 1998.
25. Davis JM, Chen MC, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry. 2003;60: 553-564.
26. Bilder RM, Goldman RS, Volavka J, et al. Neurocognitive effects of clozapine, olanzapine, risperidone and haloperidol in patients with chronic schizophrenia or schizoaffective disorder. Am J Psychiatry. 2002;159:1018-1028.
27. Purdon SE, Jones BDW, Stip E, et al. Neuropsychological change in early phase schizophrenia during twelve months of treatment with olanzapine, risperidone or haloperidol. Arch Gen Psychiatry. 2000;57:249-258.
28. Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs. 2001;15:469-494.
29. Zullino DF, Delessert D, Eap CB, et al. Tobacco and cannabis smoking cessation can lead to intoxication with clozapine or olanzapine. Int Clin Psychopharmacol. 2002;17:141-143.
30. George TP, Sernyak MJ, Ziedonis DM, Woods SW. Effects of clozapine on smoking in chronic schizophrenic outpatients. J Clin Psychiatry. 1995;56:344-346.
31. Vartian BA, Hawken ER, Delva NJ. Spontaneous long-term smoking cessation in a patient with schizophrenia after treatment with ziprasidone. Addict Disord Their Treatment. 2004;3:138-143.
32. Smelson DA, Losonczy MF, Davis CW, et al. Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Can J Psychiatry. 2002;47:671-675.
33. Kampman KM, Pettinati H, Lynch KG, et al. A pilot trial of olanzapine for the treatment of cocaine dependence. Drug Alcohol Depend. 2003;70:265-273.